Navigation Links
Media Alert From Residual Risk Reduction Initiative (R3i): 19:00 CST Sunday 9 November 2008
Date:11/7/2008

NEW ORLEANS, Louisiana, November 7 /PRNewswire/ --

- Residual Vascular Risk Reduction: The Global Call to Action

- Announcement of the Launch of the Residual Risk Reduction Initiative: R3i

KEY FACTS:

Residual Risk Reduction Initiative (R3i) calls for action to reduce the lipid related residual vascular risk unaddressed by current standards of care in millions of patients with heart disease and diabetes
WHERE:

Audubon Room, Ritz Carlton Hotel, 921 Canal Street, New Orleans, USA

WHEN:

Sunday 9 November 2008, 19:00-20:30 hrs CST (GMT- 6hrs)

WHAT: Internationally recognized specialists from North America, Europe, Asia and Japan come together to launch the Residual Risk Reduction Initiative (R3i) - a unique global program to evaluate and to reduce the excess risk of myocardial infarction, stroke, kidney disease, loss of vision and non-traumatic limb amputation which exists in many patients with heart disease and diabetes despite optimal, currently available care.

To address these important issues, the R3i engages healthcare professionals in an innovative global initiative of academic research, education and advocacy.

WHO:

Professor Frank Sacks, Vice-President R3i, Department of Nutrition Harvard School of Public Medicine, Boston, MA, USA

Professor W.Virgil Brown, International Steering Committee R3i, Charles Howard Candler Professor of Medicine, Emory University, Chief of Medicine, Atlanta, GA, USA

Professor Michel Hermans, General Secretary R3i, Department of Endocrinology and Nutrition, Cliniques Universitaires St. Luc, Université Catholique de Louvain, Brussels, Belgium


'/>"/>
SOURCE Residual Risk Reduction Initiative (R3i)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
2. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
3. Progress toward new storage media
4. Edmonton's Technology Community: Using Social Media to Raise Awareness
5. Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners
6. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
7. Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes
8. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
9. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
10. Cell Therapeutics Provides Details on Investor & Media Day to be Held in Milan, Italy on Friday, October 3, 2008
11. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: N...today that the company will be presenting at the 2... 2, 2009 at 12:30 pm local time at The New York Pa...of the company,s business strategy, research and d...nk to the live audio only presentation can be acce...
(Date:11/30/2009)...0 Biopharmaceutical company Kiadis...ve been enrolled in its,multinational registration...ed to show reduction in transplant related mortali...em cell transplantation with a mismatched,(haplo-i...for an allogeneic,stem cell transplantation but wi...
(Date:11/30/2009)...d LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/...tin Board: CYXN; ,China Yongxin,Pharmaceuticals, o...tor and,retailer of pharmaceuticals in Northeaster...ion for distribution of medicines on the Essential...ntly formalized the nation,s Essential Drug,List w...
(Date:11/30/2009)...Newswire-FirstCall/ -- BioMarin Pharmaceutical Inc...nd Drug Administration (FDA) has granted orphan dr...amifampridine phosphate, for the rare autoimmune d...3,4-DAP has previously received orphan drug design...ittee for Medicinal Products for Human Use of the ...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4
...sedly a banner year for venture capital investment...ers MoneyTree report, which is based on data from ... what does this mean for the life science industry... more particularly, what does it mean for the Midw...rill down to this level and find out (I can hear t...
... it again. He,s making sensational, not entirely a...business based on current conditions, which is nic...rd Business Review published an article by Carr ti...s that IT is now ubiquitous and available to all w...inable competitive advantage. , ,Even discounting ...
...ring we just escaped January a notoriously depres... the cold, dark and dank weather thats no surpris...t January 24 (just one week ago) was the most depr...reneurs already bear an extra psychological burden...sion might have escalated last month for reasons t...
Other Biology Technology:Life-science sector grabbed VC investment in 2004 2Life-science sector grabbed VC investment in 2004 3Whining should not get in the way of innovation 2Whining should not get in the way of innovation 3Post-January, tech entrepreneurs have reasons to be depressed 2Post-January, tech entrepreneurs have reasons to be depressed 3Post-January, tech entrepreneurs have reasons to be depressed 4
(Date:11/30/2009)...ity of Pittsburgh team overcame a major hurdle pla...se that could lead to more efficient catalysts use...toxic. The researchers reported Nov. 29 in Nature...ature stability in metallic nanoparticles, the vau...rability to extreme heat. , Gtz Veser, an associ...
(Date:11/30/2009)... Journal of Experimental Biology are pleased to a... de la Recherche Scientifique (CNRS) in the Univer... year,s JEB Outstanding Paper Prize. ,The prize ...ement and is intended to encourage young scientist..., and adds that ,we truly appreciate when authors ...
(Date:11/30/2009)...ower early bird registration rates and register on... 2010 at http://www.iofwco-ecceo10.org/ , WHA...rnational Osteoporosis Foundation (IOF) and the Eu...f Osteoporosis and Osteoarthritis (ESCEO). More th...pected to attend. The exciting scientific programm...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 1Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 2Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 3Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 4Health Strategies Group Introduces Oncology Performance Edge 5150 1Health Strategies Group Introduces Oncology Performance Edge 5150 2Health Strategies Group Introduces Oncology Performance Edge 5150 3Scientists decipher missing piece of first responder DNA repair machine 58671 1Scientists decipher missing piece of first responder DNA repair machine 58671 2Scientists decipher missing piece of first responder DNA repair machine 58671 3
...w vaccine aimed at preventing cervical cancer is n...of the human papillomavirus (HPV) responsible for ...wide study of the vaccine will be published in the...e. , Cervical cancer is the second most common cau...in nearly half a million diagnoses and 240,000 dea...
...scientific evidence is helping to build a compelli...adjunctive treatment for many cancers. , Reovir...lgary, Alberta-based Oncolytics Biotech, has shown...mor cells, in animal models, and in human clinical...ion, Reolysin®, is active against numerous cancers...
...archers at UNIVET, a spin-off of the Universitat A...al nutrition company Affinity Petcare, have develo...reproduces the characteristics of dog’s skin and w...rious lines of research related to skin biology an..., The basic structure of skin consists of an exter...
Other Biology News:Study shows continued success for new HPV vaccine against virus responsible for cervical cancer 2Dealing deadly cancers a knockout punch 2Dealing deadly cancers a knockout punch 3
Tricyclic Antidepressents ELISA Kit, Single from Bio-Quant Inc.
VZV IgM ELISA Kit, Single from Bio-Quant Inc.
Scion Image for Windows from Scion Corporation
...mbion's custom siRNA service provides the premium ...search. Custom siRNAs can be readily ordered onlin...ce, or by providing the sense and antisense siRNA ...ated and Silencer Pre-designed siRNAs, which are a...
Biology Products: